Kura Oncology - 48 Year Dividend History | KURA

Historical dividend payout and yield for Kura Oncology (KURA) since 1971. The current TTM dividend payout for Kura Oncology (KURA) as of July 19, 2019 is $0.00. The current dividend yield for Kura Oncology as of July 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.727B $0.000B
Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL, ERK inhibitor program and Menin MLL inhibitor program. Kura Oncology, Inc. is headquartered in La Jolla, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $82.919B 10.07
CSL (CSLLY) Australia $35.794B 0.00
Bio-Techne Corp (TECH) United States $7.933B 54.13